CNC Q3 2025 Earnings Call Summary | Stock Taper
Logo
CNC

CNC — Centene Corporation

NYSE


Q3 2025 Earnings Call Summary

October 29, 2025

Centene Corporation (CNC) Q3 2025 Earnings Call Summary

1. Key Financial Results and Metrics

  • Adjusted EPS: Reported at $0.50, exceeding previous expectations of $1.75 for the full year, now raised to at least $2.
  • GAAP Loss per Share: $13.50, primarily due to a $6.7 billion non-cash goodwill impairment charge.
  • Premium and Service Revenue: $44.9 billion for Q3.
  • Medicaid HBR: Improved to 93.4%, aided by a $150 million revenue adjustment from Florida's Children's Medical Services.
  • SG&A Expense Ratio: 7.0%, down from 8.3% year-over-year, reflecting better expense management.

2. Strategic Updates and Business Highlights

  • Medicaid: Continued improvements in HBR driven by rate advocacy and clinical management initiatives. Positive adjustments in Florida and progress in New York regarding fraud management.
  • Marketplace: Membership slightly increased to 5.8 million. Rate adjustments for 2026 have been filed, focusing on margin recovery amid uncertainties regarding eAPTC expirations.
  • Medicare: Consistent performance with Medicare Advantage and PDP segments, aiming for breakeven margins by 2027. The recent Star ratings showed improvement, with 60% of members in plans at or above 3.5 stars.

3. Forward Guidance and Outlook

  • 2025 Guidance: Adjusted EPS forecast raised to at least $2, reflecting better-than-expected performance in Medicaid.
  • 2026 Outlook: Initial comments suggest stable profitability in Medicaid, with expectations for margin recovery across all segments. Detailed guidance to be provided in Q4 earnings call.
  • Marketplace Strategy: Positioned for margin improvement in 2026 despite potential market contraction due to eAPTC expirations.

4. Bad News, Challenges, or Points of Concern

  • Goodwill Impairment: The significant non-cash charge reflects market cap declines and raises concerns about valuation.
  • Marketplace Utilization: Increased medical cost pressures noted in September, leading to additional provisions for Q4.
  • Regulatory Uncertainties: Potential impacts from eAPTC expirations and program integrity measures could affect enrollment and profitability.
  • Medicaid Margins: Expected flat margins for 2026 may indicate a trough year, with concerns about work requirements and state budget pressures impacting future profitability.

5. Notable Q&A Insights

  • Market Stability: Management expressed cautious optimism about competitive positioning in the Marketplace despite anticipated market contraction.
  • Enrollment Strategies: Emphasis on proactive member engagement to recapture potentially disenrolled individuals due to eAPTC changes.
  • State Rate Variability: Ongoing constructive dialogue with states regarding rate adjustments, with expectations for improved rates in Florida and other states.
  • Long-Term Commitment: Management reaffirmed commitment to the Marketplace and Medicaid segments, highlighting ongoing efforts to drive operational improvements and efficiency gains.

Overall, while Centene reported strong financial results and raised its EPS outlook, it faces significant challenges, particularly in the regulatory landscape and market dynamics, that could impact future performance.